-
EP3511008
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3511008
| EP3511008 - HEMOSTASIS COMPOSITION INCLUDING CROSS-LINKING HYALURONIC ACID DERIVATIVE MATRIX [Right-click to bookmark this link] | Status | The application has been refused Status updated on 14.06.2024 Database last updated on 24.08.2024 | |
| Former | Examination is in progress Status updated on 21.04.2023 | ||
| Former | Request for examination was made Status updated on 14.06.2019 | ||
| Former | The international publication has been made Status updated on 23.03.2018 | Most recent event Tooltip | 14.06.2024 | Refusal of application | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states BMI Korea Co., Ltd 11Cheomdan-ro 7-gil Jeju-si Jeju-do 63309 / KR | [2019/29] | Inventor(s) | 01 /
KIM, Min-Kyoung 101, 1-2 Sinseol-ro 2-gil Jeju-si Jeju-do 63227 / KR | 02 /
WOO, Koo 3, 52 Wolsannam 2-gil Jeju-si Jeju-do 63093 / KR | 03 /
BAIK, Yeong Jun 59 Irwon-ro 3-gil Gangnam-gu Seoul 06339 / KR | 04 /
MIN, Kyeong Woo 105-302 210 Gwangjang-ro Baebang-eup Asan-si Chungcheongnam-do 31471 / KR | [2019/29] | Representative(s) | Hoppe, Georg Johannes Darani Anwaltskanzlei Hohenzollerndamm 117 14199 Berlin / DE | [N/P] |
| Former [2019/29] | Hoppe, Georg Johannes Darani Anwaltskanzlei Beuckestrasse 20 14163 Berlin / DE | Application number, filing date | 17849083.5 | 06.09.2017 | [2019/29] | WO2017KR09770 | Priority number, date | KR20160114303 | 06.09.2016 Original published format: KR 20160114303 | [2019/29] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018048199 | Date: | 15.03.2018 | Language: | KO | [2018/11] | Type: | A1 Application with search report | No.: | EP3511008 | Date: | 17.07.2019 | Language: | EN | [2019/29] | Search report(s) | International search report - published on: | KR | 15.03.2018 | (Supplementary) European search report - dispatched on: | EP | 10.03.2020 | Classification | IPC: | A61K31/728, A61K38/48, A61K35/583 | [2019/29] | CPC: |
A61K31/728 (EP,KR,RU,US);
A61K35/583 (EP,KR,US);
A61K38/48 (EP,US);
A61K38/4833 (EP,KR,US);
A61P7/04 (EP,RU,US);
C08B37/0072 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/29] | Title | German: | HÄMOSTASEZUSAMMENSETZUNG MIT VERNETZENDER HYALURONSÄUREDERIVATMATRIX | [2019/29] | English: | HEMOSTASIS COMPOSITION INCLUDING CROSS-LINKING HYALURONIC ACID DERIVATIVE MATRIX | [2019/29] | French: | COMPOSITION POUR L'HÉMOSTASE COMPRENANT UNE MATRICE RÉTICULÉE DÉRIVÉE DE L'ACIDE HYALURONIQUE | [2019/29] | Entry into regional phase | 12.03.2019 | Translation filed | 05.04.2019 | National basic fee paid | 05.04.2019 | Search fee paid | 05.04.2019 | Designation fee(s) paid | 05.04.2019 | Examination fee paid | Examination procedure | 05.04.2019 | Examination requested [2019/29] | 05.10.2020 | Amendment by applicant (claims and/or description) | 25.04.2023 | Despatch of a communication from the examining division (Time limit: M04) | 05.09.2023 | Reply to a communication from the examining division | 05.03.2024 | Cancellation of oral proceeding that was planned for 13.05.2024 | 14.03.2024 | Despatch of communication that the application is refused, reason: substantive examination [2024/29] | 24.03.2024 | Application refused, date of legal effect [2024/29] | 13.05.2024 | Date of oral proceedings (cancelled) | Fees paid | Renewal fee | 30.09.2019 | Renewal fee patent year 03 | 24.09.2020 | Renewal fee patent year 04 | 23.09.2021 | Renewal fee patent year 05 | 29.09.2022 | Renewal fee patent year 06 | 26.09.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]KR101240518B ; | [Y]KR20100132878 ; | [Y]JP2010077434 ; | [Y]JP2002233542 ; | [I]WO0046253 (FERMENTECH MED LTD [GB], et al) [I] 1-15 *cf. abstract, page 1, last para., page 15, lines 6/7, claims 1-4 and 22*; | [I] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2013, no. 64, Database accession no. 2013-G53950, XP002797921 & KR101240518B B1 20130311 (GENEWEL CO LTD) [I] 1-15 * abstract * | [Y] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2011, no. 56, Database accession no. 2011-A00443, XP002797922 & KR20100132878 A 20101220 (UNIV CATHOLIC IND ACADEMIC COOP FOUND) [Y] 1-15 * abstract * | [Y] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2010, no. 27, Database accession no. 2010-E05582, XP002797923 & JP2010077434 A 20100408 (SCIVISION BIOTECH INC) [Y] 1-15 * abstract * | [Y] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2004, no. 17, Database accession no. 2004-171714, XP002797924 & JP2002233542 A 20020820 (SHISEIDO CO LTD) [Y] 1-15 * abstract * | International search | [XY]US2003060448 (RIVAROSSA ALBERTO [IT], et al) [X] 1-3, 5 * See claims 1-6. * [Y] 10-15; | [XY]CN101313915 (BEIJING TAIKEMEI TECHNOLOGY CO [CN]) [X] 1-9 * See abstract; pages 4,6 and 7; claim 1. * [Y] 10-15; | [Y]KR20130121702 (BAXTER INT [US], et al) [Y] 10-15 * See paragraphs [0015], [0016], [0033], [0034] and [0051]; claims 1, 19-21 and 23. *; | [XY]CN105400214 (UNIV BEIJING CHEMICAL TECH) [X] 1-3, 5 * See abstract; claim 1. * [Y] 10-15; | [A]WO2016100861 (BAXTER INT [US], et al) [A] 1-15* See claims 1 and 14. * |